Ab initio
calculations were carried out to understand
the reactivity and stability of some uracil derivatives, cytosine,
1-methyl cytosine, and cytidine in solvents, water, dimethyl sulfoxide
(DMSO),
n
-octanol, and chloroform. Geometries were
fully optimized at MP2 and B3LYP using the 6-31+G(d,p) basis set by
applying the Solvation Model on Density (SMD) in solvent systems.
The syn conformer of cytidine (cytidine II) is the most stable conformer
in the gas phase, while the anticonformer (cytidine IV) is most stable
in all of the solvents. Solvation free energy and polarizability values
in different solvents decrease in the order water > DMSO >
n
-octanol > chloroform, while dipole moment, first-order
hyperpolarizability, and HOMO–LUMO energy gap values follow
the order of polar protic solvent (water and
n
-octanol)
> polar aprotic solvent (DMSO) > nonpolar solvent (chloroform).
The
solvation free energy, dipole moment, polarizability, and first-order
hyperpolarizability values also follow the order of cytosine >
1-methyl
cytosine > cytidine. To illustrate that the molecular properties
correlate
well with the reactivity of the molecules,
ab initio
calculations were carried out for the reaction of uracil derivatives
with Br
2
in the gas phase, water, DMSO,
n
-octanol, and chloroform. All ground and transition state geometries
were fully optimized at B3LYP/6-31+G(d,p), and energies were also
calculated at G3MP2 for cytosine and 1-methyl cytosine. For cytosine
and 1-methyl cytosine, Gibbs energies of activation decrease with
the polarity of the solvent that is chloroform >
n
-octanol > DMSO > water, while the Gibbs energies of activation
for
the reaction with cytidine decrease in the order of water > DMSO
>
n
-octanol > chloroform. These results suggest
that solvent
polarity is very important for the stability and reactivity of uracil
derivatives. Hydrogen bonding may also play an important role mainly
for cytidine. Free energies of activation decrease with the size of
the molecule, i.e., cytosine > 1-methyl cytosine > cytidine.